Executive
Summary
The global drug
discovery services market is poised for substantial growth, driven by
escalating research and development (R&D) investments, advancements in
biotechnology, and the increasing prevalence of chronic diseases. With the
market size estimated at USD 17.47 billion in 2025 and projected to reach
approximately USD 29.45 billion by 2032, the sector offers significant
opportunities for stakeholders across the pharmaceutical and biotechnology
industries.
Request Sample Report PDF (including TOC, Graphs &
Tables): https://www.statsandresearch.com/report/40632-global-drug-discovery-services-market
Drug
Discovery Services Market Dynamics
Key
Growth Drivers
- Rising R&D Expenditure: Pharmaceutical and biopharmaceutical companies are
increasing their R&D budgets to accelerate the development of novel
therapeutics.
- Technological Advancements: Integration of artificial intelligence (AI), machine
learning, and high-throughput screening technologies enhances the
efficiency of drug discovery processes.
- Outsourcing Trends:
The high cost and complexity of in-house drug development are prompting
companies to outsource to specialized contract research organizations
(CROs).
- Focus on Precision Medicine: Personalized treatment approaches are gaining
traction, necessitating specialized drug discovery services.
Challenges
- Regulatory Hurdles:
Navigating complex regulatory frameworks can delay drug approval
processes.
- High Failure Rates:
The inherent uncertainty in drug discovery, with high attrition rates
during clinical trials, poses financial risks.
- Intellectual Property Concerns: Protecting proprietary information while collaborating
with external partners remains a critical issue.
Get up to 30%-40% Discount: https://www.statsandresearch.com/check-discount/40632-global-drug-discovery-services-market
Drug
Discovery Services Market Segmentation
By
Service Type
- Biology Services:
Dominating the market with a 35% share in 2024, driven by demand for
target identification and biomarker research.
- Medicinal Chemistry Services: Holding approximately 30% of the market, fueled by the
focus on small-molecule drug discovery and AI-driven screening techniques.
By
Drug Type
- Small Molecules:
Representing about 55% of the market in 2024, favored for their
established role in chronic disease treatments.
- Biologics and Macromolecules: Including monoclonal antibodies, recombinant proteins,
and RNA-based therapeutics, expected to grow at a CAGR of 13.1%.
By
Therapeutic Area
- Oncology:
Leading with over 42% market share, propelled by rising cancer cases and
investments in targeted therapies.
- Neurology:
Accounting for 15% of the market, with advancements in treatments for
Alzheimer's and Parkinson's diseases.
- Infectious Diseases:
Comprising 12% of the market, driven by the need for novel antivirals and
antibiotics.
By
Process Stage
- Target Discovery & Validation: Holding the largest share at 30% in 2024, supported by
advancements in genomics and proteomics.
- Hit-to-Lead Identification and Lead Optimization: Representing significant portions of the market,
emphasizing the importance of refining drug candidates.
By
Business Model
- Fee-for-Service (FFS): Dominant model with a 50% share in 2024, offering
flexibility and cost-effectiveness.
- Full-Time Equivalent (FTE): Comprising 35% of the market, facilitating long-term
partnerships with dedicated research teams.
By
End User
- Pharmaceutical and Biotechnology Companies: Collectively accounting for over 58.3% of the market
in 2024, reflecting their reliance on external drug discovery services.
- Contract Research Organizations (CROs): Holding 15% of the market, benefiting from the
outsourcing trend.
Regional
Analysis
- North America:
Leading the market due to substantial R&D investments and advanced
healthcare infrastructure.
- Europe:
Second-largest market, supported by a robust pharmaceutical industry and
collaborative research initiatives.
- Asia Pacific:
Expected to experience the highest CAGR, driven by increasing investments
in drug development in countries like China, India, and Japan.
- Latin America and Middle East & Africa: Poised for gradual expansion, attributed to improving
healthcare infrastructure and rising chronic disease prevalence.
Purchase Exclusive Report: https://www.statsandresearch.com/enquire-before/40632-global-drug-discovery-services-market
Competitive
Landscape
Prominent players in the drug discovery
services market include:
- Charles River Laboratories International
- WuXi AppTec
- Evotec AG
- Albany Molecular Research Inc. (AMRI)
- GenScript
- Domainex
- Biopta
- Merck & Co., Inc.
- Oncodesign
- Eurofins Scientific
- Halozyme
- BioNTech
- Crown Bioscience
- Intertek Group plc
- Syngene International Limited
Recent strategic developments:
- WuXi Biologics:
Sold its vaccine manufacturing facility in Ireland to Merck & Co. for
$500 million in January 2025.
- Albany Molecular Research Inc. (Curia): Expanded manufacturing facilities to support complex
small molecules and biologics.
- Halozyme Therapeutics: Proposed a $2 billion acquisition of Evotec in
November 2024, aiming to establish a leading entity in drug discovery.
- Domainex:
Participated in the Fragment-Based Lead Discovery (FBLD) conference in
September 2024, showcasing advancements in fragment screening
methodologies.
Future
Outlook
The drug discovery services market
is set to continue its upward trajectory, driven by technological innovations,
strategic collaborations, and the growing demand for personalized medicine.
Stakeholders are encouraged to invest in advanced platforms and foster
partnerships to capitalize on emerging opportunities in this dynamic sector.
Our Services:
On-Demand Reports: https://www.statsandresearch.com/on-demand-reports
Subscription Plans: https://www.statsandresearch.com/subscription-plans
Consulting Services: https://www.statsandresearch.com/consulting-services
ESG Solutions: https://www.statsandresearch.com/esg-solutions
Contact Us:
Stats and Research
Email: sales@statsandresearch.com
Phone: +91 8530698844
Website: https://www.statsandresearch.com
No comments:
Post a Comment